Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
GLP-1 Zepbound Is Approved
FDA Approves Weight Loss Medication Zepbound to Treat Sleep Apnea
The federal agency authorized the use of the Eli Lilly & Co. weight loss drug for “treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity.” In addition to the GLP-1 prescription, the FDA suggests that users reduce their calorie intake and increase their exercise.
Obesity Drug Zepbound Approved for Obstructive Sleep Apnea
The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to severe OSA in people with obesity.
FDA Approves Lilly’s Zepbound for Sleep Apnea
Averaging up to 20% of weight loss, adults taking Zepbound had 25 fewer breathing interruptions each hour as they slept.
19h
on MSN
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...
10h
on MSN
The FDA says the shortage of popular weight loss drug Zepbound is over. Here's what that means for patients.
Tirzepatide, the active ingredient in Zepbound and Mounjaro, is no longer in short supply, the FDA says.Cheaper versions of ...
Milwaukee Journal Sentinel
4d
The popular weight-loss drug Zepbound can now be used to treat sleep apnea
Zepbound
is a glucagon-like peptide 1 drug that reduces appetite and food intake. The drug's active ingredient,
tirzepatide
, is marketed as
Zepbound
for weight loss and Mounjaro as a diabetes ...
1d
on MSN
Harvey Fierstein Lost 120 lbs. on Zepbound: 'Being Fat Is Not a Choice'
Broadway icon Harvey Fierstein said he’s a “great believer” in the weight-loss medication, which helped him after he weighed ...
4d
on MSN
Novo Nordisk’s next-generation weight-loss drug matches Lilly’s Zepbound in major trial, but doesn’t surpass it
Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...
MedPage Today
5d
FDA Says Compounded Tirzepatide Must Exit the Market
Approved in 2022 for type 2 diabetes and in 2023 for chronic weight management along with diet and exercise, tirzepatide is ...
5d
A millionaire tech 'biohacker' is microdosing Zepbound to stay young
Bryan Johnson, the tech entrepreneur and millionaire who became famous for infusing his son’s plasma into his blood in an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Food and Drug Administration
Obstructive sleep apnea
Weight loss
Eli Lilly
Mounjaro
Feedback